SARS-CoV-2:宿

Prachi Jagtap1, Virendra Kumar Meena2, Susmit Sambhare2

  • 1Bioinformatics & Data Management Group, ICMR National Institute of Virology, 20A Dr. Ambedkar Road, Pune, Maharashtra, 411 001, India.

Molecular biotechnology
|October 7, 2024
PubMed
概括

尼克洛萨米德通过抑制宿主TMEM16F和病毒蛋白酶,显示出作为SARS-CoV-2重用药物的潜力. 分子模拟揭示了稳定的结合相互作用,支持其针对COVID-19的多目标治疗方法.